1. Home
  2. GDHG vs CTSO Comparison

GDHG vs CTSO Comparison

Compare GDHG & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Golden Heaven Group Holdings Ltd.

GDHG

Golden Heaven Group Holdings Ltd.

HOLD

Current Price

$2.09

Market Cap

40.5M

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.68

Market Cap

45.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDHG
CTSO
Founded
2008
1997
Country
China
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.5M
45.9M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
GDHG
CTSO
Price
$2.09
$0.68
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.38
AVG Volume (30 Days)
11.6K
86.3K
Earning Date
07-11-2025
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,288,195.00
$36,979,520.00
Revenue This Year
N/A
$7.95
Revenue Next Year
N/A
$8.80
P/E Ratio
N/A
N/A
Revenue Growth
N/A
23.89
52 Week Low
$1.82
$0.60
52 Week High
$1,968.41
$1.61

Technical Indicators

Market Signals
Indicator
GDHG
CTSO
Relative Strength Index (RSI) 34.93 49.88
Support Level $1.82 $0.67
Resistance Level $2.27 $0.74
Average True Range (ATR) 0.22 0.04
MACD 0.06 0.00
Stochastic Oscillator 25.64 44.11

Price Performance

Historical Comparison
GDHG
CTSO

About GDHG Golden Heaven Group Holdings Ltd.

Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, it manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants. it opearts in the Cayman Islands, PRC, BVI, and HK.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: